| Nov 20 |
Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
|
| Nov 10 |
Dianthus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Nov 8 |
Dianthus Therapeutics GAAP EPS of -$0.74, revenue of $2.17M
|
| Nov 7 |
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
|
| Nov 4 |
Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences
|
| Oct 15 |
Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting
|
| Oct 8 |
Dianthus: Modest Opportunity With 2 Caveats
|
| Oct 3 |
Dianthus started at outperform by Oppenheimer on DNTH103 opportunity
|
| Oct 1 |
Dianthus Therapeutics files $500M mixed shelf offering
|
| Sep 4 |
Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in September
|
